Alvotech (ALVO)
4.89
+0.03
(+0.62%)
USD |
NASDAQ |
Nov 09, 09:31
Alvotech Price : 4.89 for Nov. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 4.57 | 4.935 | 4.57 | 4.86 | 1.016M |
| Nov 05, 2026 | 4.66 | 4.66 | 4.505 | 4.55 | 752749.0 |
| Nov 04, 2026 | 4.56 | 4.765 | 4.47 | 4.67 | 668971.0 |
| Nov 03, 2026 | 4.595 | 4.66 | 4.481 | 4.54 | 541400.0 |
| Nov 02, 2026 | 4.75 | 4.76 | 4.47 | 4.48 | 1.553M |
| Oct 30, 2026 | 4.85 | 4.870 | 4.555 | 4.65 | 714818.0 |
| Oct 29, 2026 | 4.95 | 5.00 | 4.845 | 4.89 | 373364.0 |
| Oct 28, 2026 | 4.77 | 4.97 | 4.735 | 4.94 | 627919.0 |
| Oct 27, 2026 | 4.62 | 4.765 | 4.60 | 4.75 | 733474.0 |
| Oct 26, 2026 | 4.57 | 4.64 | 4.52 | 4.62 | 584890.0 |
| Oct 23, 2026 | 4.78 | 4.78 | 4.565 | 4.58 | 666201.0 |
| Oct 22, 2026 | 5.07 | 5.07 | 4.79 | 4.79 | 926997.0 |
| Oct 21, 2026 | 5.14 | 5.24 | 5.115 | 5.13 | 480527.0 |
| Oct 20, 2026 | 5.40 | 5.45 | 5.085 | 5.12 | 1.303M |
| Oct 19, 2026 | 5.13 | 5.15 | 5.020 | 5.03 | 907729.0 |
| Oct 16, 2026 | 5.27 | 5.30 | 4.95 | 5.00 | 1.059M |
| Oct 15, 2026 | 5.15 | 5.39 | 5.131 | 5.31 | 1.156M |
| Oct 14, 2026 | 5.32 | 5.51 | 5.15 | 5.17 | 1.058M |
| Oct 13, 2026 | 5.51 | 5.64 | 5.311 | 5.38 | 1.214M |
| Oct 12, 2026 | 5.79 | 5.89 | 5.44 | 5.50 | 841039.0 |
| Oct 09, 2026 | 5.67 | 5.805 | 5.565 | 5.78 | 707140.0 |
| Oct 08, 2026 | 5.83 | 5.83 | 5.605 | 5.67 | 668880.0 |
| Oct 07, 2026 | 6.10 | 6.14 | 5.845 | 5.85 | 864565.0 |
| Oct 06, 2026 | 6.07 | 6.17 | 6.00 | 6.14 | 1.219M |
| Oct 05, 2026 | 5.99 | 6.53 | 5.90 | 6.11 | 2.899M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.30 |
| Amgen, Inc. | 461.64 |
| Regeneron Pharmaceuticals, Inc. | 912.66 |
| Anika Therapeutics, Inc. | 14.75 |
| BioCryst Pharmaceuticals, Inc. | 7.775 |
Price Related Metrics
| PS Ratio | 3.216 |
| Earnings Yield | -11.40% |
| Market Cap | 1.745B |
| Operating PE Ratio | 35.24 |